Published in Vopr Virusol on January 01, 2016
Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential. Vaccine (2006) 1.16
Genetic stability of cold-adapted A/Leningrad/134/47/57 (H2N2) influenza virus: sequence analysis of live cold-adapted reassortant vaccine strains before and after replication in children. J Gen Virol (1995) 1.04
Memory T-cell immune response in healthy young adults vaccinated with live attenuated influenza A (H5N2) vaccine. Clin Vaccine Immunol (2011) 0.99
[Monoclonal immunoenzyme test-system for evaluating secretory immunity to influenza A and B viruses]. Vopr Virusol (1998) 0.85
[Genome composition analysis of the reassortant influenza viruses used in seasonal and pandemic live attenuated influenza vaccine]. Mol Gen Mikrobiol Virusol (2011) 0.84
[A comparative study of live and inactivated influenza vaccines: the organization of the observation and the results of a study of their reactogenicity and immunogenicity]. Vopr Virusol (1994) 0.81
[Restriction analysis of genome composition of live influenza vaccine]. Vopr Virusol (2011) 0.80
[Humoral and cell-mediated immune responses in humans to the A/California/07/ 2009 (H1N1) virus, A(H1N1)pdm2009]. Vopr Virusol (2013) 0.79
[Phenotyte of epidemic influenza B virus strains isolated in different years]. Vopr Virusol (2006) 0.78
[Efficacy of production of reassortant of epidemic strains and cold-adapted influenza viruses in chicken embryo and MDCK cells]. Zh Mikrobiol Epidemiol Immunobiol (2008) 0.78
[Study of biological properties of cold-adapted reassortant strain of influenza virus subtype H7N3]. Zh Mikrobiol Epidemiol Immunobiol (2009) 0.78
[PCR restriction analysis of the genome composition of reassortant cold-adapted influenza B virus strains]. Vopr Virusol (2007) 0.78
Associated seroconversions to respiratory viruses in volunteers with experimental influenza infection. Acta Virol (1976) 0.77
[The comparative characteristics of the safety, immunogenic activity and prophylactic potency of the adult and children types of live influenza vaccine in schoolchildren aged 7-14 years]. Vopr Virusol (2002) 0.77
[Hepatoprotective effects of amino acids with branched hydrocarbon chains and taurine in experimental subchronic alcohol intoxication and ethanol withdrawal]. Biomed Khim (2004) 0.77
[Effect of Point Mutations in the Polymerase Genes of the Influenza A/PR/8/34 (H1N1) Virus on the Immune Response in a Mouse Model]. Vopr Virusol (2015) 0.77
[A comparative study of the inoculation properties of live recombinant and inactivated influenza vaccines made from strain A/Philippines/2/82 (H3N2) in 8- to 15-year-old children]. Vopr Virusol (1992) 0.77
Comparison of live attenuated and inactivated influenza vaccines in schoolchildren in Russia: I. Safety and efficacy in two Moscow schools, 1987/88. Vaccine (1993) 0.77
[Stimulation of homo- and heterologic T-cell immunological memory in volunteers inoculated with live influenza A (H5N2) reassortant vaccine]. Vopr Virusol (2012) 0.77
[Effect of the composition of branched chain amino acids, taurine, and tryptophan on the amino acid metabolism in experimental models of alcoholism]. Ukr Biokhim Zh (1999) (2003) 0.77
[The inoculation properties of live recombinant influenza vaccine types A and B used separately and jointly in children 3 to 14]. Vopr Virusol (1992) 0.76
[Prophylactic effectiveness of a live recombinant influenza type A vaccine in immunizing children aged 3-14 years]. Vopr Virusol (1996) 0.76
T lymphocytes as an indicator in influenza vaccination, influenza and acute respiratory diseases. Acta Virol (1978) 0.76
Metabolic effects of mixture containing branched-chain amino acids and taurine during subchronic poisoning with barbiturates. Bull Exp Biol Med (2004) 0.76
[Characteristics of the immune response in children multiply inoculated with an inactivated influenza vaccine]. Vopr Virusol (1989) 0.75
[Toxicological evaluation of chronic exposure to dinil]. Gig Sanit (2008) 0.75
[The biological properties of 2 strains of adenovirus serotype 4]. Vopr Virusol (1972) 0.75
[The International Scientific Conference on the Optimization of Influenza Control]. Vopr Virusol (1994) 0.75
Interferon and other proinflamatory cytokine responses in vitro following infection with wild-type and cold-adapted reassortant influenza viruses. Vaccine (2006) 0.75
[Humoral and local immune response to the influenza vaccine in people of old and young ages]. Vopr Virusol (2003) 0.75
[Use of plant-origin components in roller cultivation of vaccine reassortant influenza virus strain H5N2]. Zh Mikrobiol Epidemiol Immunobiol (2011) 0.75
[B-cell and cytotoxic lymphocyte immune response to virulent, attenuated and reassortant influenza viruses]. Vopr Virusol (2002) 0.75
[The effect of saltwort, Salsola collina, on the phospholipid composition of different sections of the rat brain after ethanol administration and its withdrawal]. Eksp Klin Farmakol (1999) 0.75
[Study of the biology of intratype variants of adenovirus serotypes 1, 2, 3, 4 and 7]. Vestn Akad Med Nauk SSSR (1970) 0.75
[Current strategies for vaccine prevention of influenza]. Vopr Virusol (1996) 0.75
[Testing of apathogenic influenza virus H5N3 as a poultry live vaccine]. Vopr Virusol (2015) 0.75
[Growth characteristics of single gene mutants of A/Leningrad/134/57(H2N2) influenza virus and cold-adapted mutant A/Leningrad/134/17/57(H2N2)]. Vopr Virusol (2007) 0.75
[The choice of the optimal schedules in the vaccination procedure against influenza in elderly subjects]. Zh Mikrobiol Epidemiol Immunobiol (1998) 0.75
[Effect of taurine on the pool of central neuroactive compounds during ethanol withdrawal syndrome]. Eksp Klin Farmakol (2007) 0.75
[Results of a study of a live intranasal influenza vaccine in the immunization of children 3 to 15 years old]. Zh Mikrobiol Epidemiol Immunobiol (1988) 0.75
[Effect of infliximab on amino acid content in blood lymphocytes of alcohol-intoxicated rats]. Eksp Klin Farmakol (2012) 0.75
[Production of early cytokines after infection with A/Leningrad/134/57 (H2N2) wide-type virus and cold-adapted attenuated vaccine viruses]. Vopr Virusol (2006) 0.75
[Codon optimization of hemagglutinin as a promising tool for improving of the influenza vaccines immunogenicity]. Mol Gen Mikrobiol Virusol (2014) 0.75
[Circadian changes in levels of free amino acids in rat retina, and regulation of them by melatonin]. Dokl Akad Nauk (1998) 0.75
[GABA metabolism and neuroactive amino acids in the rat brain in morphine withdrawal syndrome]. Biomed Khim (2007) 0.75
[Protection of the elderly against influenza (a review of the literature)]. Vrach Delo (1981) 0.75
[The amino acid pool of the liver during activation of glutathione synthesis]. Ukr Biokhim Zh (1978) (1996) 0.75
[Evaluation of the anti-neuraminidase antibodies in clinical trials of the live influenza vaccine of the A(H5N2) subtype]. Vopr Virusol (2014) 0.75
[Homologous and heterologous antibody induction in influenzal infection and immunization]. Vopr Virusol (1977) 0.75
[Live influenza vaccine: laboratory markers of attenuation]. Vopr Virusol (2007) 0.75
[Comparative evaluation of the reactogenicity and antigenic activity of Soviet inactivated influenza vaccines]. Zh Mikrobiol Epidemiol Immunobiol (1984) 0.75
[A preclinical trial of the reassortant influenza virus vaccine strain A/17/Quail/Hong Kong/97/84 (H9N2)]. Vopr Virusol (2015) 0.75
[Formation of antibodies against neuraminidase of A/California/07/2009 (H1N1) influenza virus after immunization with live monovalent influenza vaccine]. Zh Mikrobiol Epidemiol Immunobiol (2012) 0.75
[Dynamics of adenovirus reproduction in the liver of newborn hamsters and changes in humoral immunity factors in experimental adenovirus hepatitis]. Vopr Virusol (1972) 0.75
Subunit influenza vaccine and its testing in clinical immunology. J Hyg Epidemiol Microbiol Immunol (1980) 0.75
[Local antibody immune responses in influenza patients and persons vaccinated with seasonal, pre-pandemic, and pandemic live attenuated influenza vaccines]. Vopr Virusol (2013) 0.75
[Formation of humoral and secretory immunity in elderly persons with different schemes of immunization with flu vaccines]. Vopr Virusol (1998) 0.75
[The generation and characteristics of reassortant influenza A virus with H5 hemagglutinin and other genes from the apathogenic virus H6N2]. Vopr Virusol (2012) 0.75
[The immunogenic properties and prophylactic efficacy of a live polyvalent influenza vaccine in children 5 to 14 years old]. Vopr Virusol (1994) 0.75
[Immunoenzyme analysis of post-vaccination secretory immunity to influenza A and B viruses using a manufactured monoclonal immunoenzyme test system]. Vopr Virusol (1998) 0.75
Enhancement of protection against influenza by complex prophylactic schemes. J Hyg Epidemiol Microbiol Immunol (1980) 0.75
Search for optimal scheme for administering live allantoic influenza vaccine. J Hyg Epidemiol Microbiol Immunol (1983) 0.75
[Specifics of neuroactive amino acid metabolism in acute ischemic stroke]. Zh Nevrol Psikhiatr Im S S Korsakova (2000) 0.75
[Effect of tritarg on proteinogenic amino acid spectrum in blood serum and lymphocytes]. Eksp Klin Farmakol (2011) 0.75
[Vaccine prophylaxis of influenza in persons with chronic pathology]. Zh Mikrobiol Epidemiol Immunobiol (1982) 0.75
[The use of L-tryptophan for correction of disbalance of central neurotransmitters in morphine withdrawal syndrome]. Eksp Klin Farmakol (2003) 0.75
[Neuromediator systems in the brain of rats in alcohol abstinence syndrome]. Eksp Klin Farmakol (2011) 0.75
[Immune response of elderly persons depending on the number of annual seasonal immunizations of live and inactivated influenza vaccines]. Vopr Virusol (1998) 0.75
[Cross protection in mice immunized with different anti-influenza preparations]. Vopr Virusol (1982) 0.75
[Local immune response to live cold-adapted reassortant influenza vaccine in children, adults, and aged people]. Vopr Virusol (2003) 0.75
[Contribution of neuraminidase of influenza viruses to the sensitivity to the serum inhibitors and reassortment efficiency]. Mol Gen Mikrobiol Virusol (2014) 0.75
[Genetic and phenotypic analysis of heterogeneous population of a cold-adapted donor of the A/Leningrad/134/17/57 (H2N2) attenuation and of the donor-based reassortant influenza vaccine strains]. Vopr Virusol (2005) 0.75
[Genetic stability of cold-adapted influenza viruses]. Vopr Virusol (2006) 0.75
[Estimation of human and animal immunological memory by testing the trogocytosis of virus-specific T lymphocytes]. Vopr Virusol (2011) 0.75
[Leading role of genes coding polymerase complex in attenuation of domestic donor viruses for A and B live influenza vaccine]. Zh Mikrobiol Epidemiol Immunobiol (2011) 0.75
Simultaneous application of influenza chemovaccine and "Vaxigrip" preparations with BCG. Acta Virol (1983) 0.75
[Taurine induces an imbalance in the pool of neuroactive amino acids and biogenic amines in regions of the brain]. Ukr Biokhim Zh (1978) (1996) 0.75
[Experience in using inactivated influenza vaccine with persons at "high risk"]. Tr Inst Im Pastera (1979) 0.75
[HOMOCYSTEINE AS A PROGNOSTIC MARKER OF ATRIAL REMODELING AND CLINICAL PICTURE IN PATIENTS WITH PAROXYSMAL AND PERSISTENT FORMS OF ATRIAL FIBRILLATION]. Klin Med (Mosk) (2016) 0.75
[In vitro proliferative activity of lymphocytes from elderly persons after separate and combined immunization with live and inactivated flu vaccines]. Vopr Virusol (2000) 0.75
[Immunogenicity of influenza virus H5N2 vaccine strain samples produced by roller cultivation in media with plant derived components]. Zh Mikrobiol Epidemiol Immunobiol (2011) 0.75
[Production of interleukin-2 in vitro and in vivo in elderly people, vaccinated with live and inactivated flu vaccines separately and combined]. Vopr Virusol (2000) 0.75
[The investigation of the safety, genetic stability and immunogenicity of live influenza vaccine for adults in vaccination of 3-6 years old children]. Vopr Virusol (2002) 0.75
[State of neuromediator systems in rat cerebellum and brain stem upon single intake of morphine]. Eksp Klin Farmakol (2009) 0.75
[The inoculative properties of cold-adapted reassortant A(H5N2) influenza strain during intranasal administration to mice]. Vopr Virusol (2007) 0.75
[Effect of non-specific inhibitors in horse serum on human adenoviruses]. Vopr Virusol (1972) 0.75
[Reactogenic properties and the immunological activity of an absorbed influenza chemical vaccine]. Tr Inst Im Pastera (1976) 0.75
[Peculiarity of reassortment of current wild type influenza viruses with master donor viruses for live influenza vaccine]. Vopr Virusol (2014) 0.75
[The temperature sensitivity of epidemic influenza A viruses as a marker of immunogenicity of reassortant vaccinal strains]. Vopr Virusol (2003) 0.75
The effects of melatonin and L-DOPA on the diurnal rhythms of free amino acids content in the rat retina. J Biol Rhythms (2000) 0.75
[Serodiagnosis in the surveillance of the influenza virus circulation during the development of the pandemic caused by the A (H1N1)pdm09]. Vopr Virusol (2015) 0.75
[Immune response to live influenza vaccine]. Vestn Ross Akad Med Nauk (2002) 0.75